Maddy summaryThis bill reauthorizes and improves the HOME Investment Partnerships Program, which provides federal funds to states and localities to develop affordable housing. It increases annual funding from $5 billion in 2024 to $6.08 billion in 2028 (with annual inflation adjustments), raises administration resource limits from 10% to 15% of funds, and establishes a new home loan guarantee program with up to $2 billion in initial funding. The bill modifies eligibility rules for affordable housing, eliminates a commitment deadline, reforms homeownership resale restrictions, and adds protections for tenants in small-scale housing projects. These changes directly affect states and localities administering the program, community housing development organizations, and low-income households living in affordable housing.
Sponsored bills
Maddy summarySRES 523 is a Senate resolution honoring the late Senator Herb Kohl of Wisconsin. The resolution expresses the Senate's sorrow at his death, directs the Secretary of the Senate to communicate it to the House of Representatives and send a copy to his family, and instructs the Senate to adjourn as a mark of respect. This procedural resolution does not create new laws or affect policy, but formally commemorates Kohl's service and legacy. It was introduced by a bipartisan group of Senators and passed unanimously on January 11, 2024.
Maddy summaryThis bill establishes a federal right for patients to access fertility treatments without unreasonable restrictions, protects health care providers who offer these services, and requires insurance coverage for such treatments. It guarantees patients the right to continue ongoing treatments under written agreements and retain control over reproductive materials. States cannot impose requirements that are more burdensome than those for comparable medical procedures or that don’t significantly advance safety. Violations can be challenged in federal court by the government, patients, or providers, while states may still enforce health/safety regulations that are necessary and least restrictive.
Maddy summaryThis resolution expresses the Senate's support for designating October 2023 as "National Co-Op Month" and commends the cooperative business model. It highlights how cooperatives - owned and controlled by members - positively impact the economy and communities across sectors like agriculture, utilities, finance, and housing. The resolution specifically recognizes cooperatives' contributions to job creation, rural economic resilience, and member ownership, without proposing new laws or funding. As a symbolic gesture, it aims to raise awareness about cooperatives' role in providing affordable services and community-focused business models.
Maddy summaryS 1507, the POWER Act, authorizes $20 million in federal funding for fiscal year 2023 to provide grants to state, local, territorial, and Tribal law enforcement agencies. The grants allow agencies to purchase chemical screening devices and train personnel to identify substances like fentanyl, methamphetamine, and other narcotics. Agencies must certify that at least one employee will be trained to operate the devices and interpret results, and must share devices with neighboring agencies when applicable. Recipients must submit annual reports on how funds were used to meet identified needs, such as improving substance identification speed and officer safety.
Maddy summaryThe Affordable Connectivity Program Extension Act of 2024 allocates $7 billion in federal funding for the Affordable Connectivity Program (ACP) in 2024. The ACP provides internet subsidies to help low-income households afford service, directly supporting millions of qualifying families. This funding ensures the program can continue operating throughout 2024, with the money remaining available until fully spent.
Maddy summaryThis bill amends federal public health grants to give preference to states that permit trained individuals to carry and administer epinephrine during anaphylactic emergencies. It requires states to certify they have civil liability protection laws covering trained individuals who act in good faith during such emergencies, and that their training standards meet medical approval. The law directly affects states seeking federal grants under Section 317 of the Public Health Service Act, as well as trained individuals (e.g., school staff, coaches) who may administer epinephrine. It does not mandate new state laws but offers grant preference to states already meeting these criteria. (Note: The title "Dillon’s Law" appears unrelated to the bill’s content, which focuses on epinephrine access, not local government authority.)
Maddy summaryThis bill retroactively restores pay, benefits, and seniority for senior military officers (O-7 rank or higher) whose promotions were delayed due to a Senate confirmation suspension starting in February 2023. It applies specifically to officers confirmed between December 5-31, 2023, who faced delays because the Senate paused its advice-and-consent process for such appointments. The bill requires the Secretary of Defense to pay retroactive compensation from a defined date (the later of 30 days after Senate calendar placement or the original appointment date) and use that date for determining the officer's seniority in their new rank. It directly affects military personnel whose career progression was impacted by the confirmation delay, without creating new policy or changing appointment procedures.
Maddy summaryThis Senate resolution designates November 2023 as National Lung Cancer Awareness Month, with additional designations for National Women’s Lung Cancer Awareness Week (first week of November) and National Lung Cancer Screening Day (second Saturday of November). It expresses support for increasing public awareness, education, and research on lung cancer prevention, early detection through screening, and treatment - particularly addressing disparities in diagnosis and access for high-risk groups like non-smokers and veterans. The resolution encourages the public to participate in awareness activities but does not create new laws or allocate funding.
Maddy summaryThis Senate resolution (SRES 510) expresses the Senate's support for respecting the FDA's scientific determination that mifepristone - a medication used for early pregnancy termination - is safe and effective. It calls for abortion care policies to be "equitable and based on science," emphasizing the FDA's authority to regulate the drug without interference, including its 2023 update allowing mail-order access. The resolution directly addresses the impact of state restrictions on medication abortion, noting that such policies disproportionately affect Black and Indigenous people, people of color, low-income individuals, rural communities, and other marginalized groups. As a non-binding resolution, it does not change laws but urges alignment with FDA science to protect access to this time-sensitive care.